{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:46:12Z","timestamp":1767134772821,"version":"build-2238731810"},"publisher-location":"Chichester, UK","reference-count":92,"publisher":"John Wiley & Sons, Ltd","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1002\/14651858.cd004162","type":"reference-entry","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T17:16:55Z","timestamp":1069435015000},"source":"Crossref","is-referenced-by-count":8,"title":["Antipsychotic drug treatment for elderly people with late-onset schizophrenia"],"prefix":"10.1002","author":[{"given":"Suwanna","family":"Arunpongpaisal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irshad","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noorulain","family":"Aqeel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suchat","family":"Paholpak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,4,22]]},"reference":[{"key":"10.1002\/14651858.CD004162-BIB1|cit1","article-title":"A multicentre, double-blind, randomised, parallel group comparison of seroquel and haloperidol in the treatment of elderly patients presenting with dementia and psychosis","author":"Bamrah","year":"2000","journal-title":"National Research Register"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD004162-BIB2|cit2","first-page":"122","article-title":"Risperidone compared with typical neuroleptic treatment in elderly schizophrenic patients","volume":"3","author":"Barak","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004162-BIB3|cit3","series-title":"150th Annual Meeting of the American Psychiatric Association; 1997 May 17-22; San Diego, USA","article-title":"The cognitive effect of risperidone in elderly schizophrenic patients a pilot double-blind comparison study with haloperidol","author":"Berman","year":"1997"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB4|cit4","first-page":"552","article-title":"Effect of risperidone on cognitive performance in elderly schizophrenic patients: a double-blind comparison study with haloperidol","volume":"31","author":"Berman","year":"1995","journal-title":"Psychopharmacology Bulletin"},{"key":"10.1002\/14651858.CD004162-BIB5|cit5","series-title":"151st Annual Meeting of the American Psychiatric Association; 1998 May 30-Jun 4; Toronto, Canada","article-title":"Effect of risperidone on cognitive function in schizophrenia","author":"Berman","year":"1998"},{"issue":"18","key":"10.1002\/14651858.CD004162-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1001\/jama.1978.03280450032019","article-title":"High and low potency neuroleptics in elderly psychiatric patients","volume":"239","author":"Branchey","year":"1978","journal-title":"Journal of the American Medical Association"},{"key":"10.1002\/14651858.CD004162-BIB7|cit7","series-title":"21st Congress of the Collegium Internationale Neuro-psychopharmacologicum; 1998 Jul 12-16; Glasgow, Scotland","article-title":"Olanzapine in the treatment of elderly patients with schizophrenia and related psychotic disorders","author":"Burns","year":"1998"},{"key":"10.1002\/14651858.CD004162-BIB8|cit8","series-title":"9th Biennial Winter Workshop on Schizophrenia; 1998 Feb 7-13; Davos, Switzerland","article-title":"Olanzapine in the treatment of elderly patients with schizophrenia and related psychotic disorders","author":"Burns","year":"1998"},{"key":"10.1002\/14651858.CD004162-BIB9|cit9","series-title":"11th Congress of The European College of Neuropsychopharmacology; 1998 Oct 31- Nov 4; Paris, France","article-title":"Olanzapine in the treatment of elderly patients with schizophrenia and related psychotic disorders","author":"Lane","year":"1998"},{"issue":"1","key":"10.1002\/14651858.CD004162-BIB10|cit10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.2165\/00002512-200118010-00004","article-title":"Antipsychotic medications and the elderly: effects on cognition and implications for use","volume":"18","author":"Byerly","year":"2001","journal-title":"Drugs and Aging"},{"key":"10.1002\/14651858.CD004162-BIB14|cit11","series-title":"11th Annual Meeting of the American Association for Geriatric Psychiatry; 1998 Mar 8-11; San Diego, USA","article-title":"Quetiapine fumarate reduces aggression","author":"Cantillon","year":"1998"},{"key":"10.1002\/14651858.CD004162-BIB11|cit12","series-title":"36th Annual Meeting of the American College of Neuropsychopharmacology; 1997","first-page":"171","article-title":"'Seroquel' (Quetiapine Fumarate) reduces hositility and aggression in patients with acute schizophrenia","author":"Cantillon","year":"1997"},{"key":"10.1002\/14651858.CD004162-BIB12|cit13","series-title":"151st Annual Meeting of the American Psychiatric Association; 1998 May 30-Jun 4; Toronto, Canada","article-title":"Efficacy of quetiapine fumarate in affective symptoms of schizophrenia","author":"Cantillon","year":"1998"},{"key":"10.1002\/14651858.CD004162-BIB13|cit14","series-title":"151st Annual Meeting of the American Psychiatric Association; 1998 May 30-Jun 4; Toronto, Canada","article-title":"Quetiapine fumarate reduces aggression and hostility in patients with schizophrenia","author":"Cantillon","year":"1998"},{"issue":"6","key":"10.1002\/14651858.CD004162-BIB15|cit15","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/1099-1166(200006)15:6<506::AID-GPS146>3.0.CO;2-V","article-title":"A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group","volume":"15","author":"Davidson","year":"2000","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD004162-BIB16|cit16","article-title":"Multi-centre double blind randomised parallel group comparison of seroquel and haloperidol in the treatment of elderly patients presenting with dementia, psychoses","author":"Evans","year":"2000","journal-title":"National Research Register"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD004162-BIB17|cit17","first-page":"154","article-title":"Long term cognitive effects of risperidone treatment in schizophrenia","volume":"3","author":"Harvey","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004162-BIB20|cit18","series-title":"52nd Institute on Psychiatric Services; 2000 Oct 25-29; Philadelphia, USA","article-title":"Long-term cognitive effects of risperidone treatment in schizophrenia","author":"Harvey","year":"2000"},{"issue":"1","key":"10.1002\/14651858.CD004162-BIB18|cit19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0920-9964(00)90795-3","article-title":"Long term cognitive effects of risperidone","volume":"41","author":"Harvey","year":"2000","journal-title":"Schizophrenia Research"},{"key":"10.1002\/14651858.CD004162-BIB19|cit20","series-title":"39th Annual Meeting of the American College of Neuropsychopharmacology; 2000; Dec 10-14; San Juan; Puerto Rico","article-title":"Long-term cognitive effects of risperidone treatment in schizophrenia","author":"Harvey","year":"2000"},{"key":"10.1002\/14651858.CD004162-BIB27|cit21","series-title":"52nd Institute on Psychiatric Services; 2000 Oct 25-29; Philadelphia, USA","article-title":"Cognitive effects of risperidone and olanzapine in patients with schizophrenia","author":"Harvey","year":"2000"},{"key":"10.1002\/14651858.CD004162-BIB26|cit22","series-title":"153rd Annual Meeting of the American Psychiatric Association; 2000 May 13-18; Chicago, USA","article-title":"Cognitive effects of risperidone and olanzapine in patients with schizophrenia or schizoaffective disorder","author":"Harvey","year":"2000"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD004162-BIB21|cit23","first-page":"77","article-title":"Cognition in elderly patients with schizophrenia: risperidone versus olanzapine","volume":"5","author":"Harvey","year":"2002","journal-title":"International Journal of Neuropsychopharmacology. Abstracts of the 23rd Congress of the Collegium Internationale Neuro-Psychopharmacologicum; 2002 Jun 23-27; Montreal, Canada"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB22|cit24","first-page":"257","article-title":"Cognitive effects of risperidone and olanzapine in patients with schizophrenia or schizoaffective disorder","volume":"11","author":"Harvey","year":"2001","journal-title":"European Neuropsychopharmacology. Abstracts of the 14th Congress of the European College of Neuropsychopharmacology; 2001 Oct 13-17; Istanbul, Turkey"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD004162-BIB23|cit25","first-page":"28","article-title":"Improved cognition in elderly schizophrenic patients: risperidone versus olanzapine","volume":"3","author":"Harvey","year":"2002","journal-title":"Schizophrenia Research. Abstracts of the 11th Biennial Winter Workshop on Schizophrenia"},{"key":"10.1002\/14651858.CD004162-BIB24|cit26","series-title":"39th Annual Meeting of the American College of Neuropsychopharmacology; 2000; Dec 10-14; San Juan; Puerto Rico","article-title":"Cognitive effects of risperidone and olanzapine in patients with schizophrenia or schizoaffective disorder","author":"Harvey","year":"2000"},{"key":"10.1002\/14651858.CD004162-BIB25|cit27","series-title":"39th Annual Meeting of the American College of Neuropsychopharmacology; 2000; Dec 10-14; San Juan; Puerto Rico","article-title":"Cognitive effects of risperidone and olanzapine in patients with schizophrenia or schizoaffective disorder","author":"Harvey","year":"2000"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD004162-BIB28|cit28","first-page":"161","article-title":"Improvement in cognition following a switch to open label ziprasidone from olanzapine, risperidone and conventional antipsychotics","volume":"3","author":"Harvey","year":"2000","journal-title":"International Journal of Neuropsychopharmacology"},{"issue":"Suppl. 3","key":"10.1002\/14651858.CD004162-BIB29|cit29","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S0924-977X(00)80302-8","article-title":"Improvement in cognition following a switch to open label ziprasidone from olanzapine, risperidone and conventional antipsychotics","volume":"10","author":"Harvey","year":"2000","journal-title":"Journal of the European College of Neuropsychopharmacology"},{"key":"10.1002\/14651858.CD004162-BIB30|cit30","series-title":"153rd Annual Meeting of the American Psychiatric Association; 2000 May 13-18; Chicago, USA","article-title":"Improvement in cognition following a switch to open label ziprasidone in outpatients with schizophrenia treated with conventional antipsychotics, olanzapine or risperidone","author":"Harvey","year":"2000"},{"issue":"Suppl. 1","key":"10.1002\/14651858.CD004162-BIB31|cit31","first-page":"125","article-title":"Effect of ziprasidone vs olanzapine on cognition in schizophrenia: a double-blind study","volume":"5","author":"Harvey","year":"2002","journal-title":"International Journal of Neuropsychopharmacology. Abstracts of the 23rd Congress of the Collegium Internationale Neuro-Psychopharmacologicum; 2002 Jun 23-27; Montreal, Canada"},{"issue":"3 Suppl.1","key":"10.1002\/14651858.CD004162-BIB32|cit32","first-page":"195","article-title":"Effects of ziprasidone on cognitive function in patients with schizophrenia: results of a double-blind trial vs. olanzapine","volume":"53","author":"Harvey","year":"2002","journal-title":"Schizophrenia Research. Abstracts of the 11th Biennial Winter Workshop on Schizophrenia"},{"issue":"Suppl. 3","key":"10.1002\/14651858.CD004162-BIB33|cit33","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0924-977X(02)80420-5","article-title":"Ziprasidone vs olanzapine for cognitive function in schizophrenia","volume":"12","author":"Harvey","year":"2002","journal-title":"European Neuropsychopharmocology \u00a0\u00a0"},{"key":"10.1002\/14651858.CD004162-BIB34|cit34","series-title":"39th Annual Meeting of the American College of Neuropsychopharmacology; 2000; Dec 10-14; San Juan; Puerto Rico","article-title":"Safety during long-term exposure to quetiapine","author":"Hellewell","year":"2000"},{"key":"10.1002\/14651858.CD004162-BIB35|cit35","series-title":"Annual Meeting of the American Psychiatric Association; 2001 May 5-10; LA, USA","article-title":"Safety during long-term exposure to quetiapine","author":"Hellewell","year":"2001"},{"issue":"1","key":"10.1002\/14651858.CD004162-BIB36|cit36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4088\/JCP.v60n0109","article-title":"The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia","volume":"60","author":"Howanitz","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD004162-BIB37|cit37","first-page":"341","article-title":"The efficacy and safety of clozapine versus chlorpromazine in geriatric schizophrenia: erratum","volume":"60","author":"Howanitz","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004162-BIB38|cit38","series-title":"149th Annual Meeting of the American Psychiatric Association; 1996 May 4-9; New York, USA","article-title":"Efficacy of clozapine versus chlorpromazine in geriatric schizophrenia","author":"Howanitz","year":"1996"},{"key":"10.1002\/14651858.CD004162-BIB39|cit39","series-title":"Annual Meeting of the American Psychiatric Association; 2001 May 5-10; LA, USA","article-title":"Risperidone versus olanzapine in elderly patients with schizophrenia","author":"Jeste","year":"2001"},{"key":"10.1002\/14651858.CD004162-BIB40|cit40","series-title":"14th Annual Meeting of the American Association for Geriatric Psychiatry; 2001 Feb 23-26; San Francisco, USA","article-title":"A comparison of prolactin concentrations in the elderly during treatment with olanzapine, haloperidol, and risperidone","author":"Kinon","year":"2001"},{"key":"10.1002\/14651858.CD004162-BIB41|cit41","series-title":"11th Annual Meeting of the American Association for Geriatric Psychiatry; 1998 Mar 8-11; San Diego, USA","article-title":"Olanzapine in the treatment of elderly patients with schizophrenia and related psychotic disorders","author":"Kuntz","year":"1998"},{"issue":"12","key":"10.1002\/14651858.CD004162-BIB42|cit42","doi-asserted-by":"crossref","first-page":"994","DOI":"10.4088\/JCP.v62n1214c","article-title":"A pilot double-blind, dose comparison study of risperidone in drug niave, first-episode schizophrenia","volume":"62","author":"Lane","year":"2001","journal-title":"Journal of Clinical Psychiatry"},{"issue":"6","key":"10.1002\/14651858.CD004162-BIB43|cit43","first-page":"234","article-title":"Management of behavioral symptoms in disturbed elderly patients: comparison of trifluoperazine and haloperidol","volume":"48","author":"Lovett","year":"1987","journal-title":"Journal of Clinical Psychiatry"},{"key":"10.1002\/14651858.CD004162-BIB44|cit44","first-page":"163","article-title":"Managing psychotic disorders through balanced receptor blockade: the zomaril tm clinical program","volume":"2","author":"Matkovits-Gupta","year":"1999","journal-title":"11th World Congress of Psychiatry; 1999 Aug 6-11; Hamburg, Germany"},{"issue":"Suppl. 1-2","key":"10.1002\/14651858.CD004162-BIB45|cit45","first-page":"238","article-title":"Safety and efficacy of iloperidone in patients with psychotic disorders: a randomized, double-blind multicenter study","volume":"49","author":"Matkovits-Gupta","year":"2001","journal-title":"Schizophrenia Research. Abstracts of 8th International Congress on Schizophrenia Research; 2001 Apr 28 - May 2; British Columbia, Canada"},{"key":"10.1002\/14651858.CD004162-BIB46|cit46","series-title":"153rd Annual Meeting of the American Psychiatric Association; 2000 May 13-18; Chicago, USA","article-title":"EPS variations in elderly","author":"Mintzer","year":"2000"},{"issue":"6","key":"10.1002\/14651858.CD004162-BIB47|cit47","first-page":"377","article-title":"Clinical trial of thiothixene (Navane) in elderly chronic schizophrenics","volume":"12","author":"Mohler","year":"1970","journal-title":"Current Therapeutic Research Clinical and Experimental"},{"key":"10.1002\/14651858.CD004162-BIB48|cit48","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1600-0447.1990.tb05314.x","article-title":"Remoxipride versus thioridazine in elderly psychotic patients","volume":"358","author":"Phanjoo","year":"1990","journal-title":"Acta Psychiatrica Scandinavica Supplementum"},{"issue":"1-2","key":"10.1002\/14651858.CD004162-BIB49|cit49","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0920-9964(97)88686-0","article-title":"Olanzapine in the treatment of elderly patients with schizophrenia and related psychotic disorders","volume":"29","author":"Reams","year":"1998","journal-title":"Schizophrenia Research"},{"issue":"4","key":"10.1002\/14651858.CD004162-BIB50|cit50","first-page":"185","article-title":"Clozapine vs haloperidol therapy in elderly chronic schizophrenic inpatients: preliminary results. A double blind, cross over randomized study","volume":"1","author":"Salganik","year":"1998","journal-title":"International Journal of Geriatric Psychopharmacology"},{"key":"10.1002\/14651858.CD004162-BIB51|cit51","series-title":"39th Annual Meeting of the American College of Neuropsychopharmacology; 2000; Dec 10-14; San Juan; Puerto Rico","article-title":"Elderly patients with schizophrenia","author":"Salzman","year":"2000"},{"key":"10.1002\/14651858.CD004162-BIB52|cit52","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1136\/bmj.1.4918.882","article-title":"Chlorpromazine in treatment of elderly psychotic women","volume":"1","author":"Seager","year":"1955","journal-title":"British Medical Journal"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB53|cit53","first-page":"276","article-title":"Superiority of olanzapine over risperidone in the control of negative symptoms of schizophrenia and related psychotic disorders in older patients","volume":"11","author":"Sutton","year":"2001","journal-title":"European Neuropsychopharmacology. Abstracts of the 14th Congress of the European College of Neuropsychopharmacology; 2001 Oct 13-17; Istanbul, Turkey"},{"issue":"2","key":"10.1002\/14651858.CD004162-BIB54|cit54","first-page":"93","article-title":"A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses","volume":"14","author":"Svestka","year":"1972","journal-title":"Activitas Nervosa Superior"},{"issue":"2","key":"10.1002\/14651858.CD004162-BIB55|cit55","first-page":"103","article-title":"Comparison of the short-term therapeutic effect of oxyprothepine and perphenazine in schizophrenic patients A controlled study","volume":"15","author":"Svestka","year":"1973","journal-title":"Activitas Nervosa Superior"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB56|cit56","first-page":"205","article-title":"Double blind comparison of isofloxythepin and haloperidol in the treatment of acute schizophrenic and schizoaffective psychoses. 29th Annual Psychopharmacology Meeting (1987, Jesenik, Czechoslovakia)","volume":"29","author":"Svestka","year":"1987","journal-title":"Activitas Nervosa Superior"},{"issue":"1","key":"10.1002\/14651858.CD004162-BIB57|cit57","first-page":"32","article-title":"Controlled cross over comparison of isofloxythepin and perphenazine in the treatment of schizophrenic psychoses","volume":"31","author":"Svestka","year":"1989","journal-title":"Activitas Nervosa Superior"},{"issue":"1","key":"10.1002\/14651858.CD004162-BIB58|cit58","first-page":"35","article-title":"Cross-over comparison of the therapeutic effects of sulpiride and perphenazine in schizophrenic and schizoaffective psychoses","volume":"31","author":"Svestka","year":"1989","journal-title":"Acta Nervosa Superior"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB59|cit59","first-page":"145","article-title":"Therapeutic results in schizophrenic and schizoaffective psychoses with sulpiride (Eglonyl Alkaloid), as compared with perphenazine (Perfenazin Spofa)","volume":"86","author":"Svestka","year":"1990","journal-title":"Ceskoslovenska Psychiatrie"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB60|cit60","first-page":"237","article-title":"Double blind clinical comparison of risperidon and haloperidol in acute schizophrenic and schizoaffective psychoses. 32nd Annual Psychopharmacological Meeting; 1990, Jesenik, Czechoslovakia","volume":"32","author":"Svestka","year":"1990","journal-title":"Activitas Nervosa Superior"},{"issue":"9","key":"10.1002\/14651858.CD004162-BIB61|cit61","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0149-2918(00)80085-5","article-title":"Long-term use of quetiapine in elderly patients with psychotic disorders","volume":"22","author":"Tariot","year":"2000","journal-title":"Clinical Therapeutics"},{"key":"10.1002\/14651858.CD004162-BIB62|cit62","series-title":"20th Congress of the Collegium Internationale Neuro-psychopharmacologicum; 1996 Jun 23-27; Melbourne, Australia","article-title":"Serotonin-dopamine antagonists in elderly schizophrenics","author":"Yamawaki","year":"1996"},{"key":"10.1002\/14651858.CD004162-BIB63|cit63","unstructured":"Lacro J Antipsychotic treatment in late life schizophrenia CRISP database. https:\/\/www-commons.cit.nih.gov\/crisp\/index.html"},{"issue":"11","key":"10.1002\/14651858.CD004162-BIB64|cit64","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1176\/ajp.156.11.1686","article-title":"Antipsychotic-induced weight gain: a comprehensive research synthesis","volume":"156","author":"Allison","year":"1999","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004162-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1136\/bmj.313.7066.1200","article-title":"Detecting skewness from summary information","volume":"313","author":"Altman","year":"1996","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004162-BIB66|cit66","unstructured":"Clarke M Oxman AD Cochrane Reviewers' Handbook 4.0 Cochrane Database of Systematic Reviews 2000"},{"key":"10.1002\/14651858.CD004162-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1176\/ajp.155.11.1512","article-title":"A randomized, placebo-controlled dose comparison trial of haloperidol for psychosis and disruptive behaviors in Alzheimer's disease","volume":"155","author":"Devanand","year":"1998","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB68|cit68","article-title":"Olanzapine for schizophrenia","author":"Duggan","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004162-BIB69|cit69","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1017\/S1041610297004560","article-title":"Clinical experience with risperidone, haloperidol, and thioridazine for dementia-associated behavioral disturbances","volume":"9","author":"Frenchman","year":"1997","journal-title":"International Journal of Psychogeriatrics"},{"issue":"1","key":"10.1002\/14651858.CD004162-BIB70|cit70","article-title":"Risperidone versus other atypical antipsychotic medication for schizophrenia","author":"Gilbody","year":"2002","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD004162-BIB71|cit71","first-page":"215","article-title":"Clinical global impression (028-CGI)","volume-title":"ECDEU Assessment Manual for Psychopharmacology, revised","author":"Guy","year":"1976"},{"issue":"7","key":"10.1002\/14651858.CD004162-BIB72|cit72","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1002\/(SICI)1099-1166(199807)13:7<484::AID-GPS808>3.0.CO;2-7","article-title":"Psychotic symptoms in the elderly: a prospective study in a population sample","volume":"13","author":"Henderson","year":"1998","journal-title":"International Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD004162-BIB73|cit73","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1192\/bjp.160.1.108","article-title":"First-rank symptoms of Schneider in late paraphrenia. Cortical structural correlates","volume":"160","author":"Howard","year":"1992","journal-title":"British Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004162-BIB74|cit74","first-page":"63","article-title":"Late paraphrenia: an update","volume":"3","author":"Howard","year":"1992","journal-title":"Journal of the Royal Society of Medicine"},{"key":"10.1002\/14651858.CD004162-BIB75|cit75","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/0920-9964(93)90114-X","article-title":"Phrenomenology of late-onset schizophrenia","volume":"9","author":"Howard","year":"1993","journal-title":"Schizophrenia Research"},{"issue":"1","key":"10.1002\/14651858.CD004162-BIB76|cit76","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Controlled Clinical Trials"},{"key":"10.1002\/14651858.CD004162-BIB77|cit77","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1176\/ajp.152.5.722","article-title":"Clinical and neuropsychological characteristics of patients with late-onset schizophrenia","volume":"152","author":"Jeste","year":"1995","journal-title":"American Journal of Psychiatry"},{"key":"10.1002\/14651858.CD004162-BIB78|cit78","doi-asserted-by":"crossref","DOI":"10.1002\/yd.2330247606","article-title":"Psychoses: Diagnosis and treatment in the elderly","volume-title":"Updates in Geriatric Psychiatry, New Directions for Mental Health Services","author":"Jeste","year":"1997"},{"key":"10.1002\/14651858.CD004162-BIB79|cit79","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3956(97)00018-6","article-title":"Adverse effect of long-term use of neuroleptics: human and animal studies","volume":"32","author":"Jeste","year":"1998","journal-title":"Journal of Psychiatric Research"},{"key":"10.1002\/14651858.CD004162-BIB80|cit80","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1097\/00019442-199924710-00010","article-title":"Conventional versus newer antipsychotics in elderly","volume":"7","author":"Jeste","year":"1999","journal-title":"American Journal of Geriatric Psychiatry"},{"key":"10.1002\/14651858.CD004162-BIB81|cit81","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia: A randomized, double-blind trial","volume":"60","author":"Katz","year":"1999","journal-title":"Journal of Clinical Psychiatry"},{"issue":"Suppl. 7","key":"10.1002\/14651858.CD004162-BIB82|cit82","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1192\/S0007125000291514","article-title":"The positive and negative syndrome scale (PANSS) rationale and standardization","volume":"155","author":"Kay","year":"1989","journal-title":"British Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB83|cit83","article-title":"Risperidone versus typical antipsychotic medication for schizophrenia","author":"Kennedy","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7358","key":"10.1002\/14651858.CD004162-BIB84|cit84","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1136\/bmj.325.7358.243","article-title":"Assessment of independent effect of olanzapine and risperidone on risk of diabetes among patients with schizophrenia: population based nested case-control study","volume":"325","author":"Koro","year":"2002","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD004162-BIB85|cit85","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/00019442-199700540-00006","article-title":"Minor physical anomalies in older patients with late-onset schizophrenia, early onset schizophrenia, depression, and Alzheimer's disease.","volume":"5","author":"Lohr","year":"1997","journal-title":"American Journal o f Geriatric Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB86|cit86","first-page":"85","article-title":"The human life span: are we reaching the outer limits?","volume":"48","author":"Olshansky","year":"1993","journal-title":"Geriatrics"},{"key":"10.1002\/14651858.CD004162-BIB87|cit87","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2466\/pr0.1962.10.3.799","article-title":"The Brief Psychiatric Rating Scale","volume":"10","author":"Overall","year":"1962","journal-title":"Psychological Reports"},{"issue":"12","key":"10.1002\/14651858.CD004162-BIB88|cit88","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1176\/ajp.146.12.1568","article-title":"A chart review study of late-onset and early-onset schizophrenia","volume":"146","author":"Pearlson","year":"1989","journal-title":"American Journal of Psychiatry"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB89|cit89","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/archpsyc.57.3.223","article-title":"Community diagnosis counts","volume":"57","author":"Regier","year":"2000","journal-title":"Archives of General Psychiatry"},{"key":"10.1002\/14651858.CD004162-BIB90|cit90","first-page":"235","article-title":"Principles of psychopharmacology","volume-title":"Verwoerdt's Clinical Geropsychiatry","author":"Salzman","year":"1990"},{"issue":"3","key":"10.1002\/14651858.CD004162-BIB91|cit91","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/00019442-199800630-00002","article-title":"Late-life onset of psychotic symptoms","volume":"6","author":"Webster","year":"1998","journal-title":"American Journal of Geriatric Psychiatry"},{"issue":"8","key":"10.1002\/14651858.CD004162-BIB92|cit92","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0006-3223(98)00100-0","article-title":"Novel antipsychotics and new onset diabetes","volume":"44","author":"Wirshing","year":"1998","journal-title":"Biological Psychiatry"}],"updated-by":[{"DOI":"10.1002\/14651858.cd004162.pub2","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,2,15]],"date-time":"2012-02-15T00:00:00Z","timestamp":1329264000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD004162\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:41:31Z","timestamp":1704962491000},"score":1,"resource":{"primary":{"URL":"https:\/\/doi.wiley.com\/10.1002\/14651858.CD004162"}},"subtitle":[],"editor":[{"given":"Suwanna","family":"Arunpongpaisal","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2003,4,22]]},"references-count":92,"URL":"https:\/\/doi.org\/10.1002\/14651858.cd004162","relation":{},"subject":[],"published":{"date-parts":[[2003,4,22]]}}}